These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 36672316)
1. Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors. Cai D; Yu H; Wang X; Mao Y; Liang M; Lu X; Shen X; Guan W Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672316 [TBL] [Abstract][Full Text] [Related]
2. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies. Zhao H; Wang H; Zhou Q; Ren X Cancer Biol Med; 2021 Sep; 18(4):981-91. PubMed ID: 34553849 [TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes. Chen J; Chen J; Wang L J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536 [TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD Front Immunol; 2022; 13():1049884. PubMed ID: 36420257 [TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X Front Immunol; 2023; 14():1222719. PubMed ID: 37529035 [TBL] [Abstract][Full Text] [Related]
6. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Liu Z; Meng X; Tang X; Zou W; He Y Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914 [TBL] [Abstract][Full Text] [Related]
7. Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures. Magara T; Nakamura M; Nojiri Y; Yoshimitsu M; Kano S; Kato H; Morita A Front Oncol; 2023; 13():1106434. PubMed ID: 37081973 [TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis. Zhang X; Yao J; Xie M; Liang Y; Lin X; Song J; Bao X; Ma X; Wang Y; Zhang Y; Liu Y; Han W; Pan L; Xue X Int Immunopharmacol; 2024 Oct; 140():112790. PubMed ID: 39088920 [TBL] [Abstract][Full Text] [Related]
9. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer. Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y Front Immunol; 2022; 13():868155. PubMed ID: 35664009 [TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma. Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038 [TBL] [Abstract][Full Text] [Related]
11. Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma. Wakasu S; Tagawa T; Haratake N; Kinoshita F; Oku Y; Ono Y; Takenaka T; Oda Y; Shimokawa M; Mori M Cancer Immunol Immunother; 2023 Jun; 72(6):1823-1834. PubMed ID: 36688996 [TBL] [Abstract][Full Text] [Related]
12. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589 [TBL] [Abstract][Full Text] [Related]
13. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients. Zhang K; Xie X; Zou LH; Guo SQ Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495 [TBL] [Abstract][Full Text] [Related]
15. Tertiary lymphoid structures in the era of cancer immunotherapy. Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904 [TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications. Wang S; Wang H; Li C; Liu B; He S; Tu C MedComm (2020); 2024 Mar; 5(3):e489. PubMed ID: 38469550 [TBL] [Abstract][Full Text] [Related]
17. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. Zhang Q; Wu S Front Immunol; 2022; 13():1063711. PubMed ID: 36713409 [TBL] [Abstract][Full Text] [Related]
18. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors. Hayashi Y; Makino T; Sato E; Ohshima K; Nogi Y; Kanemura T; Honma K; Yamashita K; Saito T; Tanaka K; Yamamoto K; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Wada H; Morii E; Eguchi H; Doki Y Br J Cancer; 2023 Jun; 128(12):2175-2185. PubMed ID: 37016103 [TBL] [Abstract][Full Text] [Related]
19. Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients. Cai D; Wang X; Yu H; Bai C; Mao Y; Liang M; Xia X; Liu S; Wang M; Lu X; Du J; Shen X; Guan W Clin Transl Immunology; 2024; 13(2):e1489. PubMed ID: 38322490 [TBL] [Abstract][Full Text] [Related]
20. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma. Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y Front Immunol; 2023; 14():1096220. PubMed ID: 36776859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]